Imaging and T Category for Prostate Cancer in the 8th Edition of the Union for International Cancer Control TNM Classification.
Eur Urol Oncol. 2019 Jul 12;:
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.
PLoS Med. 2019 Jul;16(7):e1002847
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.
Eur Urol Oncol. 2019 May;2(3):333-336
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
Eur Urol Oncol. 2019 May;2(3):231-238
Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter-Nephroureterectomy and Ureterectomy Specimens: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Am J Surg Pathol. 2019 Jun 11;:
Gleason grade patterns in nodal metastasis and corresponding prostatectomy specimens: impact on patient outcome.
Histopathology. 2019 Jun 08;:
The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Mol Cancer Res. 2018 04;16(4):682-695
Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question.
Eur Urol. 2019 May 10;:
Predicting biochemical recurrence and prostate cancer specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of screen and clinically detected prostate cancer patients.
BJU Int. 2019 May 04;:
Mol Metab. 2019 Apr 10;: